Skip to content

TuHURA Biosciences, Inc. HURA Accounts payable and other current liabilities

Accounts payable and other current liabilities at other companies

Inogen logo
InogenINGN
-$1.34M-119%
TMC the metals company Inc. logo
TMC the metals company Inc.TMC
$8.53M+3,906%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$9.41M-176%
FTI Consulting logo
FTI ConsultingFCN
$36.27M+374%
Hudson Technologies logo
Hudson TechnologiesHDSN
-$4.75M-194%
Trilogy Metals logo
Trilogy MetalsTMQ
-$1.64M-2,537%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s accounts payable and other current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s accounts payable and other current liabilities?
TuHURA Biosciences, Inc. (HURA) reported accounts payable and other current liabilities of $452.01K in Q1 2026.
How has TuHURA Biosciences, Inc.'s accounts payable and other current liabilities changed year-over-year?
TuHURA Biosciences, Inc.'s accounts payable and other current liabilities increased by 1.5% year-over-year, from $445.54K to $452.01K.